United Services Automobile Association Mirati Therapeutics, Inc. Transaction History

United Services Automobile Association

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2019 Nov 13, 2019	SELL	$77.91 - $109.6 $531,813 - $748,129	-6,826 Closed	0 $0
Q2 2019 Aug 16, 2019	SELL	$59.49 - $104.71 $20,107 - $35,391	-338 Reduced 4.72%	6,826 $703,000
Q1 2019 May 13, 2019	SELL	$43.65 - $78.95 $2,531 - $4,579	-58 Reduced 0.8%	7,164 $525,000
Q4 2018 Feb 13, 2019	BUY	$32.0 - $47.43 $5,536 - $8,205	173 Added 2.45%	7,222 $306,000
Q3 2018 Nov 13, 2018	BUY	$47.1 - $62.7 $92,739 - $123,456	1,969 Added 38.76%	7,049 $332,000
Q2 2018 Aug 10, 2018	BUY	$26.05 - $52.4 $132,334 - $266,192	5,080 New	5,080 $250,000

3.57M

36.6K

Ticker MRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 55,609,800
Description
Mirati Therapeutics, Inc., a clinical-stage oncology company, develops product candidates to address the genetic and immunological promoters of cancer in the United States. The company develops MRTX849, a KRAS G12C inhibitor, which is in Phase 1/2 clinical trial for treating non-small cell lung (NSCL), colorectal, pancreatic, and other cancers; ...

Get notified when there are updates to the investment portfolio of United Services Automobile Association, based on Form 13F filings with the SEC.

Stay updated on United Services Automobile Association with notifications on news.